• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

陷入困境的楔形传感器?从解决CardioMEMS设备的肺动脉压力波形传输衰减故障中吸取的教训。

Wedged Sensor in Distress? Lessons Learned from Troubleshooting Dampened Transmitted PA Waveforms of CardioMEMS Device.

作者信息

Singh Robby, Scarfone Santo, Zughaib Marcel

机构信息

Providence Hospital, Michigan State University, USA.

Georgetown University, USA.

出版信息

Case Rep Cardiol. 2020 Feb 11;2020:3856940. doi: 10.1155/2020/3856940. eCollection 2020.

DOI:10.1155/2020/3856940
PMID:32095291
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7036126/
Abstract

. Cardiovascular disease is a leading cause of morbidity and mortality with heart failure constituting a large portion of this spectrum. Heart failure patients have 90-day readmission rates of nearly 41% associated with a high expense. Numerous strategies to reduce readmissions have been attempted with the CardioMEMS pulmonary artery pressure monitoring system as one of the more successful ones. As this device becomes used more frequently, it is important to recognize procedural complications. We present of a rare complication where a patient underwent successful device placement and was subsequently found to have dampened waveforms which were due to device migration. . A 79-year-old male underwent successful CardioMEMS placement due to recurrent heart failure hospitalizations. 6 months later, the transmitted waveforms appeared dampened, and repeat angiography revealed a device that had migrated. Rather than abandoning the device, it was recalibrated and continued to transmit data and helped manage the patient's heart failure. . CardioMEMS is a cost-effective tool to help reduce heart failure hospitalizations. Device migration is a rare complication and can lead to inaccurate data. However, as seen in this case, the device can be successfully recalibrated and can continue to be utilized to help reduce heart failure admissions.

摘要

心血管疾病是发病和死亡的主要原因,心力衰竭在这一疾病谱中占很大比例。心力衰竭患者的90天再入院率接近41%,费用高昂。人们尝试了多种减少再入院的策略,CardioMEMS肺动脉压力监测系统是较为成功的策略之一。随着该设备使用越来越频繁,认识到其操作并发症很重要。我们报告了一例罕见并发症,一名患者成功植入设备后,随后发现波形衰减,原因是设备移位。一名79岁男性因反复心力衰竭住院而成功植入CardioMEMS。6个月后,传输的波形出现衰减,再次血管造影显示设备已移位。该设备并未被弃用,而是重新校准,继续传输数据,并有助于管理患者的心力衰竭。CardioMEMS是一种有助于减少心力衰竭住院的经济有效工具。设备移位是一种罕见并发症,可能导致数据不准确。然而,如本病例所示,该设备可成功重新校准,并可继续用于帮助减少心力衰竭入院。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12de/7036126/58145a5b7ae2/CRIC2020-3856940.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12de/7036126/671bcccf5e11/CRIC2020-3856940.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12de/7036126/e597c9cb866e/CRIC2020-3856940.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12de/7036126/a42412b42a8a/CRIC2020-3856940.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12de/7036126/344d8504c922/CRIC2020-3856940.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12de/7036126/51b9b871d55e/CRIC2020-3856940.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12de/7036126/58145a5b7ae2/CRIC2020-3856940.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12de/7036126/671bcccf5e11/CRIC2020-3856940.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12de/7036126/e597c9cb866e/CRIC2020-3856940.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12de/7036126/a42412b42a8a/CRIC2020-3856940.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12de/7036126/344d8504c922/CRIC2020-3856940.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12de/7036126/51b9b871d55e/CRIC2020-3856940.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12de/7036126/58145a5b7ae2/CRIC2020-3856940.006.jpg

相似文献

1
Wedged Sensor in Distress? Lessons Learned from Troubleshooting Dampened Transmitted PA Waveforms of CardioMEMS Device.陷入困境的楔形传感器?从解决CardioMEMS设备的肺动脉压力波形传输衰减故障中吸取的教训。
Case Rep Cardiol. 2020 Feb 11;2020:3856940. doi: 10.1155/2020/3856940. eCollection 2020.
2
CardioMEMS in a Busy Cardiology Practice: Less than Optimal Implementation of a Valuable Tool to Reduce Heart Failure Readmissions.繁忙心脏病学实践中的CardioMEMS:一种用于减少心力衰竭再入院的宝贵工具的实施效果欠佳
Cardiol Res Pract. 2018 Nov 7;2018:4918757. doi: 10.1155/2018/4918757. eCollection 2018.
3
CardioMems® device implantation reduces repeat hospitalizations in heart failure patients: A single center experience.CardioMems® 设备植入可减少心力衰竭患者的再次住院率:单中心经验。
JRSM Cardiovasc Dis. 2019 Feb 24;8:2048004019833290. doi: 10.1177/2048004019833290. eCollection 2019 Jan-Dec.
4
Large pulmonary artery pseudoaneurysm after CardioMEMS implantation: a case report.CardioMEMS植入术后的大型肺动脉假性动脉瘤:一例报告
Eur Heart J Case Rep. 2022 Mar 22;6(4):ytac113. doi: 10.1093/ehjcr/ytac113. eCollection 2022 Apr.
5
Impact of CardioMEMS device placement on lifestyle modifications: a "pseudo-placebo" effect beyond the expected?心脏微机电系统(CardioMEMS)装置植入对生活方式改变的影响:一种超出预期的“假安慰剂”效应?
J Int Med Res. 2018 Aug;46(8):3195-3199. doi: 10.1177/0300060518774123. Epub 2018 May 28.
6
Current Role of the CardioMEMS Device for Management of Patients with Heart Failure.心力衰竭患者管理中心肌力学监测仪设备的当前作用。
Curr Cardiol Rep. 2019 Jul 27;21(9):98. doi: 10.1007/s11886-019-1194-9.
7
A new option for monitoring heart failure. First experience in Spain with CardioMEMS.心力衰竭监测的新选择。西班牙首例 CardioMEMS 经验。
Med Clin (Barc). 2021 Jan 8;156(1):26-28. doi: 10.1016/j.medcli.2020.07.028. Epub 2020 Oct 12.
8
Hemoptysis After CardioMEMS Implantation: Case Report and Review.心脏MEMS植入术后咯血:病例报告与文献复习
Am J Case Rep. 2018 Mar 31;19:382-385. doi: 10.12659/ajcr.908508.
9
Effects of pressure variation and atrial fibrillation on CardioMEMS HF measured pulmonary artery diastolic pressure: comparison of device-averaged and visually inspected waveforms.压力变化和心房颤动对CardioMEMS HF测量的肺动脉舒张压的影响:设备平均波形与目视检查波形的比较
Physiol Meas. 2017 Jun;38(6):1094-1103. doi: 10.1088/1361-6579/aa6edb. Epub 2017 May 11.
10
Early Detection of Subclinical Aortic Valve Endocarditis with the CardioMEMS Heart Failure System.使用CardioMEMS心力衰竭系统早期检测亚临床主动脉瓣心内膜炎
Am J Case Rep. 2017 Jun 14;18:665-668. doi: 10.12659/ajcr.903071.

引用本文的文献

1
Dysfunctional Implantable Pulmonary Artery Sensor Device (CardioMEMS) in Group 2 Pulmonary Hypertension.第2组肺动脉高压中功能失调的植入式肺动脉传感器装置(CardioMEMS)
JACC Case Rep. 2025 Jan 15;30(2):102801. doi: 10.1016/j.jaccas.2024.102801.
2
CardioMEMS monitoring device migration: A rare complication.心脏微机电监测设备移位:一种罕见的并发症。
Radiol Case Rep. 2024 Apr 13;19(7):2596-2599. doi: 10.1016/j.radcr.2024.03.049. eCollection 2024 Jul.
3
Anatomical characterization of pulmonary artery and implications to pulmonary artery pressure monitor implantation.

本文引用的文献

1
CardioMems® device implantation reduces repeat hospitalizations in heart failure patients: A single center experience.CardioMems® 设备植入可减少心力衰竭患者的再次住院率:单中心经验。
JRSM Cardiovasc Dis. 2019 Feb 24;8:2048004019833290. doi: 10.1177/2048004019833290. eCollection 2019 Jan-Dec.
2
An update on the CardioMEMS pulmonary artery pressure sensor.CardioMEMS肺动脉压力传感器的最新情况。
Ther Adv Cardiovasc Dis. 2019 Jan-Dec;13:1753944719826826. doi: 10.1177/1753944719826826.
3
Postmarketing Adverse Events Related to the CardioMEMS HF System.
肺动脉解剖学特征及其对肺动脉压监测仪植入的影响。
Sci Rep. 2023 Nov 22;13(1):20528. doi: 10.1038/s41598-023-47612-9.
4
Clinical Update of the Latest Evidence for CardioMEMS Pulmonary Artery Pressure Monitoring in Patients with Chronic Heart Failure: A Promising System for Remote Heart Failure Care.慢性心力衰竭患者的 CardioMEMS 肺动脉压力监测最新证据的临床更新:远程心力衰竭治疗的有前途的系统。
Sensors (Basel). 2021 Mar 27;21(7):2335. doi: 10.3390/s21072335.
与 CardioMEMS HF 系统相关的上市后不良事件。
JAMA Cardiol. 2017 Nov 1;2(11):1277-1279. doi: 10.1001/jamacardio.2017.3791.
4
Economic burden of hospitalizations of Medicare beneficiaries with heart failure.医疗保险受益人心力衰竭住院的经济负担。
Risk Manag Healthc Policy. 2017 May 10;10:63-70. doi: 10.2147/RMHP.S130341. eCollection 2017.
5
Cost-Effectiveness of Remote Cardiac Monitoring With the CardioMEMS Heart Failure System.使用CardioMEMS心力衰竭系统进行远程心脏监测的成本效益
Clin Cardiol. 2017 Jul;40(7):430-436. doi: 10.1002/clc.22696. Epub 2017 Mar 8.
6
Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial.肺动脉压指导慢性心力衰竭治疗调整的持续疗效:CHAMPION 随机试验的完整随访结果。
Lancet. 2016 Jan 30;387(10017):453-61. doi: 10.1016/S0140-6736(15)00723-0. Epub 2015 Nov 9.
7
CHAMPION trial rationale and design: the long-term safety and clinical efficacy of a wireless pulmonary artery pressure monitoring system.CHAMPION 试验原理和设计:一种无线肺动脉压监测系统的长期安全性和临床疗效。
J Card Fail. 2011 Jan;17(1):3-10. doi: 10.1016/j.cardfail.2010.08.002.